Development of gold nanoparticle-based biosensors for COVID-19 diagnosis.
COVID-19 diagnosis
Carbon nanotube
Gold nanoparticles
Point-of-care testing
Quantum dot
SARS-CoV-2
Journal
Beni-Suef University journal of basic and applied sciences
ISSN: 2314-8543
Titre abrégé: Beni Suef Univ J Basic Appl Sci
Pays: England
ID NLM: 101758435
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
03
2022
accepted:
30
08
2022
entrez:
12
9
2022
pubmed:
13
9
2022
medline:
13
9
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative organism of coronavirus disease 2019 (COVID-19) which poses a significant threat to public health worldwide. Though there are certain recommended drugs that can cure COVID-19, their therapeutic efficacy is limited. Therefore, the early and rapid detection without compromising the test accuracy is necessary in order to provide an appropriate treatment for the disease suppression. Nanoparticles (NPs) can closely mimic the virus and interact strongly with its proteins due to their morphological similarities. NPs have been widely applied in a variety of medical applications, including biosensing, drug delivery, antimicrobial treatment, and imaging. Recently, NPs-based biosensors have attracted great interest for their biological activities and specific sensing properties, which allows the detection of analytes such as nucleic acids (DNA or RNA), aptamers, and proteins in clinical samples. Further, the advances of nanotechnologies have enabled the development of miniaturized detection systems for point-of-care biosensors, a new strategy for detecting human viral diseases. Among the various NPs, the specific physicochemical properties of gold NPs (AuNPs) are being widely used in the field of clinical diagnostics. As a result, several AuNP-based colorimetric detection methods have been developed. The purpose of this review is to provide an overview of the development of AuNPs-based biosensors by virtue of its powerful characteristics as a signal amplifier or enhancer that target pathogenic RNA viruses that provide a reliable and effective strategy for detecting of the existing or newly emerging SARS-CoV-2.
Sections du résumé
Background
UNASSIGNED
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative organism of coronavirus disease 2019 (COVID-19) which poses a significant threat to public health worldwide. Though there are certain recommended drugs that can cure COVID-19, their therapeutic efficacy is limited. Therefore, the early and rapid detection without compromising the test accuracy is necessary in order to provide an appropriate treatment for the disease suppression.
Main body
UNASSIGNED
Nanoparticles (NPs) can closely mimic the virus and interact strongly with its proteins due to their morphological similarities. NPs have been widely applied in a variety of medical applications, including biosensing, drug delivery, antimicrobial treatment, and imaging. Recently, NPs-based biosensors have attracted great interest for their biological activities and specific sensing properties, which allows the detection of analytes such as nucleic acids (DNA or RNA), aptamers, and proteins in clinical samples. Further, the advances of nanotechnologies have enabled the development of miniaturized detection systems for point-of-care biosensors, a new strategy for detecting human viral diseases. Among the various NPs, the specific physicochemical properties of gold NPs (AuNPs) are being widely used in the field of clinical diagnostics. As a result, several AuNP-based colorimetric detection methods have been developed.
Short conclusion
UNASSIGNED
The purpose of this review is to provide an overview of the development of AuNPs-based biosensors by virtue of its powerful characteristics as a signal amplifier or enhancer that target pathogenic RNA viruses that provide a reliable and effective strategy for detecting of the existing or newly emerging SARS-CoV-2.
Identifiants
pubmed: 36092513
doi: 10.1186/s43088-022-00293-1
pii: 293
pmc: PMC9444098
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
111Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Anal Chem. 2016 Jul 5;88(13):6781-8
pubmed: 27299694
ACS Nano. 2020 Oct 20;:
pubmed: 33079516
Ann Intern Med. 2020 Sep 15;173(6):450-460
pubmed: 32496919
Int Immunopharmacol. 2021 Jun;95:107493
pubmed: 33721758
Curr Opin Solid State Mater Sci. 2021 Dec;25(6):100964
pubmed: 34729031
J Mater Chem B. 2020 Oct 28;8(41):9449-9465
pubmed: 32955066
Biosens Bioelectron. 2022 Jan 1;195:113669
pubmed: 34607117
Clin Infect Dis. 2020 Jun 16;:
pubmed: 32556191
NPJ Digit Med. 2021 Jun 10;4(1):96
pubmed: 34112939
Anal Chem. 2021 Apr 6;93(13):5365-5370
pubmed: 33755419
Anal Bioanal Chem. 2021 Jul;413(16):4137-4159
pubmed: 34008124
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):100-105
pubmed: 33476316
Turk J Med Sci. 2020 Apr 15;50(SI-1):549-556
pubmed: 32293832
ACS Appl Bio Mater. 2020 Aug 17;3(8):4922-4932
pubmed: 35021736
Biosens Bioelectron. 2021 May 1;179:113076
pubmed: 33601132
Transp Res Interdiscip Perspect. 2020 May;5:100111
pubmed: 34171015
Beni Suef Univ J Basic Appl Sci. 2021;10(1):60
pubmed: 34642633
Nanomedicine (Lond). 2007 Oct;2(5):681-93
pubmed: 17976030
PLoS One. 2021 Apr 29;16(4):e0250942
pubmed: 33914804
Viruses. 2021 Jun 24;13(7):
pubmed: 34202815
Anal Chem. 2020 Aug 4;92(15):10196-10209
pubmed: 32573207
Anal Chem. 2021 Jun 22;93(24):8585-8594
pubmed: 34081452
Anal Chem. 2021 Jan 12;93(1):184-197
pubmed: 33215911
Talanta. 2021 Mar 1;224:121883
pubmed: 33379092
Clin Infect Dis. 2020 Apr 27;:
pubmed: 32338708
Toxicol Ind Health. 2018 Mar;34(3):200-210
pubmed: 29506458
Science. 2018 Apr 27;360(6387):439-444
pubmed: 29449508
Nanotechnology. 2008 Oct 8;19(40):405101
pubmed: 21832608
Anal Chem. 2021 Mar 30;93(12):5259-5266
pubmed: 33733739
Food Chem. 2015 Mar 1;170:470-83
pubmed: 25306373
J Colloid Interface Sci. 2016 Jun 1;471:127-135
pubmed: 26994353
Saudi J Biol Sci. 2022 May;29(5):3456-3465
pubmed: 35233172
Glob Health Med. 2021 Dec 31;3(6):413-414
pubmed: 35036625
Mol Pharm. 2013 Mar 4;10(3):831-47
pubmed: 23360440
Expert Rev Anti Infect Ther. 2020 Dec;18(12):1201-1211
pubmed: 32749914
Clin Infect Dis. 2020 Dec 31;71(11):2996-3001
pubmed: 32511679
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1642-1647
pubmed: 33382679
Chem Soc Rev. 2014 Feb 7;43(3):744-64
pubmed: 24220322
Front Public Health. 2022 May 16;10:896343
pubmed: 35651866
Biosens Bioelectron. 2019 Jan 15;124-125:115-121
pubmed: 30343154
New Microbes New Infect. 2021 May;41:100846
pubmed: 33614039
Diagnostics (Basel). 2016 Nov 22;6(4):
pubmed: 27879660
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1835-1844
pubmed: 34774862
J Infect Dis. 2021 Feb 3;223(2):206-213
pubmed: 33535237
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33139420
J Nanobiotechnology. 2018 May 11;16(1):48
pubmed: 29751767
Isr Med Assoc J. 2020 Apr;22(4):203-210
pubmed: 32286019
Biosens Bioelectron. 2020 Oct 15;166:112437
pubmed: 32692666
J Infect Public Health. 2016 May-Jun;9(3):216-9
pubmed: 27106390
Anal Methods. 2020 Dec 7;12(46):5613-5620
pubmed: 33184619
Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705
pubmed: 32845525
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Sens Actuators Rep. 2021 Nov;3:100025
pubmed: 35047829
J Pharm Anal. 2022 Jun;12(3):355-364
pubmed: 35811614
ACS Nano. 2021 Jun 16;:
pubmed: 34133128
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:37-46
pubmed: 30889711
N Engl J Med. 2020 Oct 8;383(15):1492-1494
pubmed: 32937062
Acta Virol. 2020;64(4):396-408
pubmed: 32985200
Colloids Surf B Biointerfaces. 2018 Nov 1;171:485-493
pubmed: 30077906
Biosens Bioelectron. 2016 Jun 15;80:208-214
pubmed: 26849348
Clin Chim Acta. 2006 Jan;363(1-2):120-6
pubmed: 16214124
Analyst. 2013 Feb 21;138(4):981-90
pubmed: 23304696
Sensors (Basel). 2021 Feb 10;21(4):
pubmed: 33578726
PLoS Pathog. 2021 Sep 22;17(9):e1009701
pubmed: 34551020
JAMA Netw Open. 2021 Feb 1;4(2):e2037129
pubmed: 33570576
Bull Natl Res Cent. 2021;45(1):94
pubmed: 34035647
J Clin Pathol. 2011 Jun;64(6):546-8
pubmed: 21460391
GeoJournal. 2022 Mar 3;:1-6
pubmed: 35261429
BMJ Glob Health. 2019 Feb 1;4(Suppl 2):e001105
pubmed: 30815285
Sensors (Basel). 2021 Oct 01;21(19):
pubmed: 34640901
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):455-461
pubmed: 30836779
J Proteomics. 2012 Jun 6;75(10):2811-23
pubmed: 22119545
Molecules. 2018 Feb 10;23(2):
pubmed: 29439409
Sci Adv. 2021 Dec 03;7(49):eabj1476
pubmed: 34851667
Chem Soc Rev. 2012 Apr 7;41(7):2849-66
pubmed: 22182959
Sensors (Basel). 2020 Nov 18;20(22):
pubmed: 33218097
Drug Res (Stuttg). 2020 Sep;70(9):389-400
pubmed: 32746481
Int J Infect Dis. 2020 Jul;96:464-466
pubmed: 32470604
Nanoscale. 2017 Dec 21;10(1):18-33
pubmed: 29211091